Some positive changes have been made since the first draft was published in January, 2015, especially with respect to patient preferences. However, we believe that the revised guideline remains unfit for purpose and is a missed opportunity to improve the lives of patients with type 2 diabetes (Lancet)
Diabetes News
Category: Audits
Policy evaluation in diabetes prevention and treatment using a population-based macro simulation model: the MICADO model
Validation by comparison with independent empirical data showed that the MICADO model simulates the natural course of diabetes and its micro- and macrovascular complications well (Diabetic Medicine)
A decade in diabetes specialist services, 2000 to 2011, in England: the views of consultant diabetologists and diabetes specialist nurses amidst persistent healthcare delivery change
A willingness to innovate and work differently to improve services was identified; however, clinicians must be supported through organizational changes to ensure people with diabetes receive high-quality care. The disruptive nature of organizational change was a recurrent theme throughout the decade (Diabetic Medicine)
Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? a long-term health economic analysis for the UK
Although associated with improved clinical outcomes, insulin intensification as practiced in the UK has a relatively high cost per QALY and may not lead to cost-effective outcomes for patients with type 2 diabetes as currently defined by UK cost-effectiveness thresholds (Diabetes Research and Clinical Practice)
UK service level audit of insulin pump therapy in paediatrics
The number of children and young people on continuous subcutaneous insulin infusion therapy is consistent with numbers estimated by NICE. There is a worrying lack of funded healthcare professional time. The audit also identified gaps in the provision of structured education and absence of written inpatient guidelines (Diabetic Medicine)
Inequality in Diabetes-Related Hospital Admissions in England by Socioeconomic Deprivation and Ethnicity
More deprived areas had higher rates of inpatient admissions and readmissions due to diabetes (PLoS ONE)
National Paediatric Diabetes Audit
National Paediatric Diabetes Audit Annual Report, covering 2013-14 (Royal College of Paediatrics and Child Health)
Taking Control: Supporting people to self-manage their diabetes
Examines in detail why many individuals are not getting the support they need to self-manage their diabetes and what the NHS, clinical commissioning groups, healthcare professionals and providers can do to address this (All-Party Parliamentary Group for Diabetes)
Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial
Given conventional thresholds of cost-effectiveness, the intensive treatment delivered in ADDITION was not cost-effective compared with routine care for individuals with screen-detected diabetes in the UK. The intervention may be cost-effective if it can be delivered at reduced cost (Diabetic Medicine)
Estimating Cost-Effectiveness in Type 2 Diabetes
A marked difference in treatment cost-effectiveness was demonstrated when comparing routine clinical practice with guideline-advocated therapy escalation. This is important to both health care professionals and the wider health economic community with respect to understanding the true cost-effectiveness profile of any particular T2DM therapy option (Medical Decision Making)
Together for Health – A Diabetes Delivery Plan
A Delivery Plan up to 2016 for NHS Wales and its partners
Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison
These results suggest that there are substantial variations in glycaemic control among people with Type 1 diabetes between the data sources and that there is room for improvement in all populations, especially in young adults (Diabetic Medicine)
Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison
These results suggest that there are substantial variations in glycaemic control among people with Type 1 diabetes between the data sources and that there is room for improvement in all populations, especially in young adults (Diabetic Medicine)
The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84)
Diabetic complications are associated with substantial immediate and long-term healthcare costs. Our comprehensive new estimates of these costs, derived from detailed recent UK Prospective Diabetes Study post-trial data, should aid researchers and health policy analyses (Diabetic Medicine)
International Comparison of Medicines Usage: Quantitative Analysis
This report was commissioned by the Association of the British Pharmaceutical Industry (ABPI) and updates to 2012/13 the quantitative analysis of UK usage of medicines per head of total population compared to that in other countries in 2008/09 which was published in the 2010 Richards Report: Extent and causes of international variations in drug usage (ABPI)
National Diabetes Audit – 2012-2013: Report 1, Care Processes and Treatment Targets
This national report from the tenth year of the audit presents key findings on key care processes and treatment target achievement rates from 2012-2013 in all age groups in England and Wales (HSCIC)
Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985—2011
Continued increases in the incidence of diagnosed diabetes combined with declining mortality have led to an acceleration of lifetime risk and more years spent with diabetes, but fewer years lost to the disease for the average individual with diabetes (The Lancet Diabetes & Endocrinology)
Prescribing for Diabetes, England – 2005-06 to 2013-14
This is the latest in a series of annual reports published by the Health and Social Care Information Centre on Prescribing for Diabetes in England, within primary care (HSCIC)
Cost of diabetic foot disease to the National Health Service in England
The cost of diabetic foot disease is substantial. Ignorance of the cost of current care may hinder commissioning of effective services for prevention and management in both community and secondary care (Diabetic Medicine)
National Diabetes Inpatient Audit 2013
Key findings about the quality of care of inpatients with diabetes in England and Wales
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- Next Page »
Glycosmedia is also available as an App: